@article{article, title  = {{Use of cyclin-dependent kinase (CDK) 4/6 inhibitors for hormone receptor-positive, human epidermal growth factor receptor 2-negative, metastatic breast cancer: a roundtable discussion by The Breast Cancer Therapy Expert Group (BCTEG)}},

 publisher = {{Springer Science and Business Media LLC}},

 url = {{http://eprints.whiterose.ac.uk/133369/ }},

 year = {{2018}},

 month = {{5}},

 author = {{Abraham J and Coleman R and Elias A and Holmes FA and Kalinsky K and Kittaneh M and Lower E and Mahtani R and Terry Mamounas E and Pegram M and Vogel C}},

 doi = {{10.1007/s10549-018-4783-1}},

 volume = {{171}},

 journal = {{Breast Cancer Research and Treatment}},

 issue = {{1}},

 pages = {{11-20}},

 note = {{Accessed on 2025/10/10}}}